Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma.

Literature DB >> 8063620

Chemotherapy targeting regional lymph nodes by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma.

Y Akamo¹, I Mizuno, T Yotsuyanagi, T Ichino, N Tanimoto, T Yamamoto, M Nagata, H Takeyama, N Shinagawa, J Yura.

Abstract

We investigated the delivery of adriamycin (ADR) to the regional lymph nodes of the stomach following the gastric submucosal injection of liposomal adriamycin (Lipo-ADR) in 34 gastric carcinoma patients, as well as following intravenous administration of free ADR (F-ADR) in another 18 patients. Prior to radical gastrectomy, Lipo-ADR was endoscopically injected into the gastric submucosa adjacent to the primary tumor via a needle-tipped catheter. After Lipo-ADR injection, the ADR concentration in the primary and secondary drainage lymph nodes was higher than in the other regional lymph nodes. Thus, the regional nodes more susceptible to metastasis showed higher levels of ADR. In contrast, the intravenous administration of F-ADR produced a similar and far lower ADR concentration in all the nodes. Delivery of ADR to the primary drainage lymph nodes following injection of 5 ml of Lipo-ADR was compared with delivery to the left gastric artery lymph nodes after intravenous administration of an equal dose of F-ADR. The ADR levels (micrograms/g) after gastric submucosal injection were 15.1 +/- 8.30 on day 1 (n = 4); and 11.9 +/- 4.80 on day 4 (n = 6). Those after intravenous administration were 0.29 +/- 0.10 on day 1 (n = 4); and 0.36 +/- 0.0 on day 4 (n = 2). The differences between the two groups were significant (P < 0.05). The ADR levels after the gastric submucosal injection were far higher than those after intravenous administration. These findings indicate that the gastric submucosal injection of Lipo-ADR can specifically deliver ADR to the regional lymph nodes at high concentrations. Such preoperative adjuvant chemotherapy targeting the regional lymph nodes may be useful for preventing the lymph node recurrence of gastric carcinoma.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1994 PMID： 8063620 PMCID： PMC5919527 DOI： 10.1111/j.1349-7006.1994.tb02409.x

Source DB: PubMed Journal: Jpn J Cancer Res ISSN： 0910-5050

adriamycian liposomal adriamycin free adriamycin multilamellar vesicles the area under the concentration‐time curve

19 in total

1. Anticancer agents adsorbed by activated carbon particles, a new form of dosage enhancing efficacy on lymphnodal metastases.

Authors: A Hagiwara; T Ahn; T Ueda; A Iwamoto; T Ueda; T Torii; T Takahashi
Journal: Anticancer Res Date: 1986 Sep-Oct Impact factor: 2.480

Review 2. The anthracycline antineoplastic drugs.

Authors: R C Young; R F Ozols; C E Myers
Journal: N Engl J Med Date: 1981-07-16 Impact factor: 91.245

3. Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration.

Authors: K Hirano; C A Hunt
Journal: J Pharm Sci Date: 1985-09 Impact factor: 3.534

4. Surgical treatment of early gastric cancer.

Authors: H Kitaoka; K Yoshikawa; T Hirota; M Itabashi
Journal: Jpn J Clin Oncol Date: 1984-06 Impact factor: 3.019

5. Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro.

Authors: H T Rupniak; R D Whelan; B T Hill
Journal: Int J Cancer Date: 1983-07-15 Impact factor: 7.396

6. Surgical chemotherapy against lymph node metastases: an experimental study.

Authors: N Tanigawa; K Satomura; Y Hikasa; M Hashida; S Muranishi; H Sezaki
Journal: Surgery Date: 1980-02 Impact factor: 3.982

7. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation.

Authors: F Szoka; D Papahadjopoulos
Journal: Proc Natl Acad Sci U S A Date: 1978-09 Impact factor: 11.205

8. Lymph node localization of non-specific antibody-coated liposomes.

Authors: S Mangat; H M Patel
Journal: Life Sci Date: 1985-05-20 Impact factor: 5.037

9. Activated carbon particles as anti-cancer drug carrier into regional lymph nodes.

Authors: A Hagiwara; T Takahashi; T Ueda; A Iwamoto; T Torii
Journal: Anticancer Drug Des Date: 1987-04

10. Enhanced lymphatic delivery of mitomycin C conjugated with dextran.

Authors: Y Takakura; S Matsumoto; M Hashida; H Sezaki
Journal: Cancer Res Date: 1984-06 Impact factor: 12.701

7 in total

Review 1. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

Authors: Yumei Xie; Taryn R Bagby; M S Cohen; M Laird Forrest
Journal: Expert Opin Drug Deliv Date: 2009-08 Impact factor: 6.648

Review 2. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors: Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal: Nat Rev Drug Discov Date: 2015-10-16 Impact factor: 84.694

3. Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats.

Authors: Deanna R Worley; Ryan J Hansen; Luke A Wittenburg; Laura S Chubb; Daniel L Gustafson
Journal: Anticancer Res Date: 2016-10 Impact factor: 2.480